Down-regulation of transforming growth factor β receptors by androgen in ovarian cancer cells

Cancer Research

Volumn 60, Issue 4, 2000, Pages 929-935

  Evangelou, Andreas ^a,c   Jindal, Sangita K ^d,e   Brown, Theodore J ^b,c   Letarte, Michelle ^a,c,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ENDOGLIN; ESTRADIOL 17BETA DEHYDROGENASE; HYDROXYFLUTAMIDE; PROGESTERONE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION;

DIHYDROTESTOSTERONE; DOWN-REGULATION; FEMALE; FLUTAMIDE; GENE EXPRESSION REGULATION; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0034652478     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Risch, H. A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer Inst., 90: 1774-1786, 1998.
2. Hamilton, T. C., Davies, P., and Griffiths, K. Androgen and oestrogen binding in cytosols of human ovarian tumours. J. Endocrinol., 90: 421-431, 1981.
3. Kuhnel, R., de Graaff, J., Rao, B. R., and Stolk, J. G. Androgen receptor predominance in human ovarian carcinoma. J. Steroid Biochem., 26: 393-397, 1987.
4. Slotman, B. J., Baak, J. P., and Rao, B. R. Correlation between nuclear DNA content and steroid receptor status in ovarian cancer. Eur. J. Obstet. Gynecol. Reprod. Biol., 38: 221-227, 1991.
5. Chadha, S., Rao, B. R., Slotman, B. J., van Vroonhoven, C. J., and van der Kwast, H. An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors. Hum. Pathol., 24: 90-95, 1993.
6. Cardillo, M. R., Petrangeli, E., Aliotta, N., Salvatori, L., Ravenna, L., Chang, C., and Castagna, G. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study. J. Exp. Clin. Cancer Res., 17: 231-237, 1998.
7. Helzlsouer, K. J., Alberg, A. J., Gordon, G. B., Longcope, C., Bush, T. L., Hoffman, S. C., and Comstock, G. W. Serum gonadotropins and steroid hormones and the development of ovarian cancer. J. Am. Med. Assoc., 274: 1926-1930, 1995.
8. Schildkraut, J. M., Schwingl, P. J., Bastos, E., Evanoff, A., and Hughes, C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet. Gynecol., 88: 554-559, 1996.
9. Silva, E. G., Tornos, C., Fritsche, H. A., El-Naggar, A., Gray, K., Ordonez, N. G., Luna, M., and Gershenson, D. The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod. Pathol., 10: 879-883, 1997.
10. Berchuck, A., Rodriguez, G., Oli, G., Whitaker, R., Boente, M. P., Arrick, B. A., Clarke-Pearson, D. L., and Bastf, R. C. Regulation of growth of normal ovarian epithelial cells and ovarian cell lines by transforming growth factor-β. Am. J. Obstet. Gynecol., 166: 676-683, 1992.
11. Hurteau, J., Rodriguez, G. C., Whitaker, R. S., Shah, S., Mills, G., Bast, R. C., and Berchuck, A. Transforming growth factor-β inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer (Phila.), 74: 93-99, 1994.
12. Markowitz, S. D., and Roberts, A. B. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev., 7: 93-102, 1996.
13. Filmus, J., and Kerbel, R. S. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-β during tumor progression. Cur. Opin. Oncol., 5: 123-129, 1993.
14. Wrana, J. L. TGF-β receptors and signaling mechanisms. Miner. Electrolyte Metab., 24: 120-130, 1998.
15. Lopez-Casillas, F., Cheifetz, S., Doody, J., Andres, J. L., Lane, W. S., and Massague, J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell, 67: 785-795, 1991.
16. Barbara, N. P., Wrana, J. L., and Letarte, M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. J. Biol. Chem., 274: 584-594, 1999.
17. Cheifetz, S., Bellon, T., Cales, C., Vera, S., Bemabeu, C., Massague, J., and Letarte, M. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J. Biol. Chem., 267: 19027-19030, 1992.
18. Lastres, P., Letamendia, A., Zhang, H., Rius, C., Almendro, N., Raab, U., Lopez, L. A., Langa, C., Fabra, A., Letarte, M., and Bernabeu, C. Endoglin modulates cellular responses to TGF-β1. J. Cell Biol., 133: 1109-1121, 1996.
19. Hirte, H. W., Clark, D. A., Mazurka, J., O'Connell, G., and Rusthoven, J. A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinoma. Gynecol. Oncol., 44: 223-226, 1998.
20. Marks, A., Ballinger, J. R., Reilly, R. M., Law, J., and Baumal, R. A novel anti-seminoma monoclonal antibody (M2A) labelled with technetium-99m: potential application for radioimmunoscintigraphy. Br. J. Urol., 75: 225-229, 1995.
21. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1986.
22. Jindal, S. K., Ishii, E., Letarte, M., Vera, S., Teerds, K. J., and Dorrington, J. H. Regulation of transforming growth factor-α gene expression in an ovarian surface epithelial cell line derived from a human carcinoma. Biol. Reprod., 52: 1027-1037, 1995.
23. Murphy, L. D., Herzog, C. E., Rudick, J. B., Fojo, A. T., and Bates, S. E. Use of the polymerase chain reaction in the quantiation of mdr-1 gene expression. Biochemistry, 29: 10351-10356, 1990.
24. Chang, C., Kokontis, J., and Liao, S. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc. Natl. Acad. Sci. USA, 85: 7211-7215, 1988.
25. Yen, S., and Chang, C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA, 93: 5517-5521, 1996.
26. Heisler, L. E., Evangelou, A., Lew, A. M., Trachtenberg, J., Elsholtz, H. P., and Brown, T. J. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol. Cell. Endocrinol., 126: 59-73, 1997.
27. Puy, L., MacLusky, N. J., Becker, L., Karsan, N., Trachtenberg, J., and Brown, T. J. Immunocytochemical detection of androgen receptor in human temporal cortex: characterization and application of polyclonal androgen receptor antibodies in frozen and paraffin-embedded tissues. J. Steroid Biochem. Mol. Biol., 55: 197-209, 1995.
28. 3H]methyltrienolone (R1881) in the presence of progesterone receptors. Endocrinology, 104: 1007-1013, 1979.
29. Guo, Y., and Kyprianou, N. Overexpression of transforming growth factor (TGF)-β1 type II receptor restores TGF-β1 sensitivity and signaling in human prostate cancer cells. Cell Growth Differ., 9: 185-193, 1998.
30. Miyamoto, H., Yeh, S., Wilding, G., and Chang, C. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc. Natl. Acad. Sci. USA, 95: 7379-7384, 1998.
31. Zeinoun, Z., Teugels, E., de Bleser, P. J., Neyns, B., Geerts, A., and de Greve, J. Insufficient TGF-β1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines. Anticancer Res., 19: 413-120, 1999.
32. Havrilesky, L. J., Hurteau, J. A., Whitaker, R. S., Elbendary, A., Wu, S., Rodriguez, G. C., Bast, R. C., and Berchuk, A. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor-β. Cancer Res., 55: 944-948, 1995.
33. Gao, T., Brantle, K., Bol, E., and McPhaul, M. J. RGF, (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays, Mol. Endocrinol., 13: 1645-1656, 1999.
34. Alen, P., Claessens, F., Schoenmakers, E., Swinnen, J. V., Verhoeven, G., Romhauts, W., and Peeters, B. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1α with multiple steroid receptors and identification of an internally deleted ELE1β isoform. Mol. Endocrinol., 13: 117-128. 1999.
35. Lau, K. M., Mok. S. C., and Ho, S. M. Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc. Natl. Acad. Sci. USA, 96: 5722-5727, 1999.
36. Wilson, A. P., Fox, H., Scott, I. V., Lee, H., Dent, M., and Golding, P. R. A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumors. Br. J. Cancer, 63: 102-108, 1991.
37. Ridderheim, M., Mahlck, C. G., Selstam, G., Stendahl, U., and Backstrom, T. Peritoneal fluid and hCG influence on steroid production from ovarian tumor tissue in vitro. Anticancer Res., 14: 1753-1758, 1994.